Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
ST. LOUIS, April 06, 2016 -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its first quarter earnings on Monday, April 25, 2016 after the market closes and will hold its quarterly conference call to discuss first quarter results on Tuesday, April 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
This call is being webcast and can be accessed at the Investor Information section of Express Scripts’ web site at www.express-scripts.com/corporate. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.
A slide presentation will also be posted on Express Scripts’ website. Following the conference call, both the slide presentation and the webcast will remain available on the Investor Information section of Express Scripts’ website for 14 days.
About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
Eric Slusser, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected]
